TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Leo Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
103,139
|
105,491
|
126,062 |
Financial expenses |
2,565
|
1,553
|
304 |
Earnings before taxes |
2,820
|
4,140
|
5,689 |
EBITDA |
3,980
|
4,374
|
6,037 |
Total assets |
67,956
|
88,371
|
151,858 |
Current assets |
63,758
|
83,069
|
140,850 |
Current liabilities |
40,032
|
54,700
|
71,136 |
Equity capital |
22,114
|
19,922
|
18,529 |
- share capital |
672
|
668
|
727 |
Employees (average) |
23
|
18
|
31 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
32.5%
|
22.5%
|
12.2% |
Turnover per employee |
4,484
|
5,861
|
4,067 |
Profit as a percentage of turnover |
2.7%
|
3.9%
|
4.5% |
Return on assets (ROA) |
7.9%
|
6.4%
|
3.9% |
Current ratio |
159.3%
|
151.9%
|
198.0% |
Return on equity (ROE) |
12.8%
|
20.8%
|
30.7% |
Change turnover |
-2,895
|
-10,360
|
-10,809 |
Change turnover % |
-3%
|
-9%
|
-8% |
Chg. No. of employees |
5
|
-13
|
-4 |
Chg. No. of employees % |
28%
|
-42%
|
-11% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.